BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27036038)

  • 1. hsa-miR-9 controls the mobility behavior of glioblastoma cells via regulation of MAPK14 signaling elements.
    Ben-Hamo R; Zilberberg A; Cohen H; Efroni S
    Oncotarget; 2016 Apr; 7(17):23170-81. PubMed ID: 27036038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
    Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
    Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
    Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
    Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
    Yerukala Sathipati S; Huang HL; Ho SY
    BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44.
    Yeh M; Wang YY; Yoo JY; Oh C; Otani Y; Kang JM; Park ES; Kim E; Chung S; Jeon YJ; Calin GA; Kaur B; Zhao Z; Lee TJ
    Sci Rep; 2021 Apr; 11(1):9219. PubMed ID: 33911148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal control of ADAM17/EGFR/Akt signaling and miR-145 drives GBM invasiveness.
    Guo Y; He X; Zhang M; Qu Y; Gu C; Ren M; Wang H; Ning W; Li J; Yu C; Zhang H
    J Neurooncol; 2020 Apr; 147(2):327-337. PubMed ID: 32170633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme.
    Barbagallo D; Condorelli A; Ragusa M; Salito L; Sammito M; Banelli B; Caltabiano R; Barbagallo G; Zappalà A; Battaglia R; Cirnigliaro M; Lanzafame S; Vasquez E; Parenti R; Cicirata F; Di Pietro C; Romani M; Purrello M
    Oncotarget; 2016 Jan; 7(4):4746-59. PubMed ID: 26683098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells.
    Zhang S; Lai N; Liao K; Sun J; Lin Y
    Folia Neuropathol; 2015; 53(3):236-44. PubMed ID: 26443314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
    Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
    Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
    Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X
    Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of miR-21 signaling by MPS1 in human glioblastoma.
    Maachani UB; Tandle A; Shankavaram U; Kramp T; Camphausen K
    Oncotarget; 2016 Aug; 7(33):52912-52927. PubMed ID: 25991676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells.
    Aldaz B; Sagardoy A; Nogueira L; Guruceaga E; Grande L; Huse JT; Aznar MA; Díez-Valle R; Tejada-Solís S; Alonso MM; Fernandez-Luna JL; Martinez-Climent JA; Malumbres R
    PLoS One; 2013; 8(10):e77098. PubMed ID: 24155920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-155 Regulates Glioma Cells Invasion and Chemosensitivity by p38 Isforms In Vitro.
    Liu Q; Zou R; Zhou R; Gong C; Wang Z; Cai T; Tan C; Fang J
    J Cell Biochem; 2015 Jul; 116(7):1213-21. PubMed ID: 25535908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
    Gao X; Jin W
    Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-target cross-talks: Key players in glioblastoma multiforme.
    Toraih EA; Aly NM; Abdallah HY; Al-Qahtani SA; Shaalan AA; Hussein MH; Fawzy MS
    Tumour Biol; 2017 Nov; 39(11):1010428317726842. PubMed ID: 29110584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-106a-5p facilitates human glioblastoma cell proliferation and invasion by targeting adenomatosis polyposis coli protein.
    Li D; Wang Z; Chen Z; Lin L; Wang Y; Sailike D; Luo K; Du G; Xiang X; Jiafu GD
    Biochem Biophys Res Commun; 2016 Dec; 481(3-4):245-250. PubMed ID: 27815074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
    Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-Regulation of microRNA-183 Promotes Cell Proliferation and Invasion in Glioma By Directly Targeting NEFL.
    Wang ZY; Xiong J; Zhang SS; Wang JJ; Gong ZJ; Dai MH
    Cell Mol Neurobiol; 2016 Nov; 36(8):1303-1310. PubMed ID: 26879754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
    Shi Y; Chen C; Yu SZ; Liu Q; Rao J; Zhang HR; Xiao HL; Fu TW; Long H; He ZC; Zhou K; Yao XH; Cui YH; Zhang X; Ping YF; Bian XW
    Clin Cancer Res; 2015 Sep; 21(17):4004-13. PubMed ID: 26023083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS.
    Fiore D; Donnarumma E; Roscigno G; Iaboni M; Russo V; Affinito A; Adamo A; De Martino F; Quintavalle C; Romano G; Greco A; Soini Y; Brunetti A; Croce CM; Condorelli G
    Oncotarget; 2016 Apr; 7(15):19531-47. PubMed ID: 26799668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.